A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Cancer clinical trials in Melbourne, FL
Cancer research makes up a large share of the studies on the Space Coast, and many local cancer studies run through Cancer Care Centers of Brevard. Studies often cover lung cancer and breast cancer, along with digestive system cancers; see our oncology clinical trials page and our guides to lung cancer treatment and breast cancer treatment.
Other clinical trials on the Space Coast
Studies in Melbourne, Palm Bay, and Viera also cover fatty liver disease, Alzheimer's disease and memory loss, depression and other mental health conditions, kidney disease, and weight loss.
Do clinical trials in Melbourne pay?
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything. The institutional review board that oversees each study must approve any payment before the study begins, and FDA guidance treats payment as a way to recognize your time, not as a benefit of taking part. If you receive payment, it is usually spread across the visits you complete.
Our guide explains how much clinical trials pay and how payment is decided.
Can I join a cancer clinical trial while getting standard treatment?
Sometimes. Some cancer studies add an investigational treatment to standard care, others compare a new treatment with the standard one, and some require that you have not yet started treatment. Talk to your oncologist before you apply; our guide to standard treatment versus clinical trials can help you weigh the options.
How to join a clinical trial in Melbourne
- Identify your trial. Use the filters on this page to narrow the list by condition or phase, or search a diagnosis such as breast cancer or fatty liver disease.
- Check the location. Each study lists the sites where it recruits, so confirm it has a site in Melbourne, Palm Bay, Viera, or elsewhere in Brevard County.
- Explore study details. Read the eligibility criteria and, where listed, the number of visits and how long the study lasts before applying.
- Complete the health profile. Click "See if you qualify" to begin the 5-step application. Have ready your diagnosis and when it was made, the medicines you take, and any recent test results.
- Submit the application. A clinical trial coordinator reviews it and contacts you to discuss next steps. Nothing is decided until informed consent, and participation is voluntary at every step.
Our guide to finding clinical trials near you covers each step in more detail.
Clinical trials near Melbourne: Orlando, Port St. Lucie, and Daytona Beach
Studies in Melbourne, Palm Bay, Viera, and other Brevard County towns appear on this page. For more options, our Orlando page covers the larger research programs about an hour northwest, Port St. Lucie is about an hour south, and Daytona Beach is about 70 miles north; studies across the state are on our Florida clinical trials page.